Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Women's Health Initiative: Risk of stroke

Women's Health Initiative: Risk of stroke
Kaplan-Meier estimates of cumulative hazard rates of stroke. In the Women's Health Initiative, combined estrogen-progestin therapy was associated with a significant increase in stroke when compared with placebo. The intention-to-treat hazard ratio was 1.31, 95% CI 1.02-1.68.
Data from: Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. JAMA 2003; 289:2673.
Graphic 74704 Version 4.0

Do you want to add Medilib to your home screen?